ArticleGlobalization and health2011
The Health Systems Funding Platform: Is this where we thought we were going?
Article in Globalization and health, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Article
- Sector-wide or disease-specific? Implications of trends in development assistance for health for the SDG era.Health policy and planning · 2018Article
- Global constitutionalism, applied to global health governance: uncovering legitimacy deficits and suggesting remedies.Globalization and health · 2016Article
- The Code of Practice and its enduring relevance in Europe and Eastern and Southern Africa.Human resources for health · 2016Article
- Exploring the influence of the Global Fund and the GAVI Alliance on health systems in conflict-affected countries.Conflict and health · 2015Article
- A concept in flux: questioning accountability in the context of global health cooperation.Globalization and health · 2014Article
- How can health remain central post-2015 in a sustainable development paradigm?Globalization and health · 2014Article
- Analysis of human resources for health strategies and policies in 5 countries in Sub-Saharan Africa, in response to GFATM and PEPFAR-funded HIV-activities.Globalization and health · 2013Article
- Global health initiative investments and health systems strengthening: a content analysis of global fund investments.Globalization and health · 2013Article
- The health systems funding platform and World Bank legacy: the gap between rhetoric and reality.Globalization and health · 2013Article
- Health systems frameworks in their political context: framing divergent agendas.BMC public health · 2012Article
- Development cooperation for health: reviewing a dynamic concept in a complex global aid environment.Globalization and health · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn March 2009, the Task Force for Innovative International Financing for Health Systems recommended "a health systems funding platform for the Global Fund, GAVI Alliance, the World Bank and others to coordinate, mobilize, streamline and channel the flow of existing and new international resources to support national health strategies." Momentum to establish the Health Systems Funding Platform was swift, with the World Bank convening a Technical Workshop on Health Systems Strengthening (HSS), and serial meetings organized to progress the agenda. Despite its potential significance, there has been little comment in peer-reviewed literature, though some disquiet in the international development community around the scope of the Platform and the capacity of the partners, which appears disproportionate to the available information.
methodsThis case study uses documentary analysis, participant observation and 24 in-depth interviews to examine the processes of development and key issues raised by the Platform.
resultsThe findings show a fluid and volatile process, with debate over whether ongoing engagement in HSS by Global Fund and GAVI represents a dilution of organizational focus, risking ongoing support, or a paradigm shift that facilitates the achievement of targeted objectives, builds systems capacity, and will attract additional resources. Uncertainty in the development of the Platform reflects the flexibility of the recently formed global health initiatives, and the instability of donor commitments, particularly in the current financial climate. But implicit in the conflict is tension between key global stakeholders over defining and ownership of the health systems agenda.
conclusionsThe tensions appear to have been resolved through a focus on national planning, applying International Health Partnership principles, though the global financial crisis and key personnel changes may yet alter outcomes. Despite its dynamic evolution, the Platform may offer an incremental path towards increasing integration around health systems, that has not been previously possible.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.